These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17600288)

  • 1. IRX-2 and thymosin alpha1 (Zadaxin) increase T lymphocytes in T lymphocytopenic mice and humans.
    Hadden JW; Verastegui E; Hadden E
    Ann N Y Acad Sci; 2007 Sep; 1112():245-55. PubMed ID: 17600288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopharmacology of thymosin alpha1 and cytokine synergy.
    Naylor PH; Quadrini K; Garaci E; Rasi G; Hadden JW
    Ann N Y Acad Sci; 2007 Sep; 1112():235-44. PubMed ID: 17567942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical studies with IRX-2 and thymosin alpha1 in combination therapy.
    Naylor PH; Hadden JW
    Ann N Y Acad Sci; 2010 Apr; 1194():162-8. PubMed ID: 20536465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymosin alpha 1: from bench to bedside.
    Garaci E; Favalli C; Pica F; Sinibaldi Vallebona P; Palamara AT; Matteucci C; Pierimarchi P; Serafino A; Mastino A; Bistoni F; Romani L; Rasi G
    Ann N Y Acad Sci; 2007 Sep; 1112():225-34. PubMed ID: 17600290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodeficiency and cancer: prospects for correction.
    Hadden JW
    Int Immunopharmacol; 2003 Aug; 3(8):1061-71. PubMed ID: 12860163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulatory function of orally administered thymosin alpha1.
    Chen XM; Jiang HL; Zhou LF; Pan XP; Hu ZR; Liu RH; Chen XM; Chen Z
    J Zhejiang Univ Sci B; 2005 Sep; 6(9):873-6. PubMed ID: 16130188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and application of a yeast expression system for thymosin alpha1.
    Chen F; Chen XM; Chen Z; Jiang HL; Pan XP; Hu ZR; Liu RH; Chen XM
    Biocell; 2005 Dec; 29(3):253-9. PubMed ID: 16524246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thymosin alpha-1-transformed Bifidobacterium promotes T cell proliferation and maturation in mice by oral administration.
    Shao C; Tian G; Huang Y; Liang W; Zheng H; Wei J; Wei C; Yang C; Wang H; Zeng W
    Int Immunopharmacol; 2013 Mar; 15(3):646-53. PubMed ID: 23352493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymosin α1 promotes the activation of myeloid-derived suppressor cells in a Lewis lung cancer model by upregulating Arginase 1.
    Yuan C; Zheng Y; Zhang B; Shao L; Liu Y; Tian T; Gu X; Li X; Fan K
    Biochem Biophys Res Commun; 2015 Aug; 464(1):249-55. PubMed ID: 26111447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo].
    Ma YL; Zheng Z; Li BD; Xie SJ; Li GX; Yan QH; Cai JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Nov; 23(11):1046-9. PubMed ID: 17988589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes.
    Yao Q; Doan LX; Zhang R; Bharadwaj U; Li M; Chen C
    Immunol Lett; 2007 Jun; 110(2):110-20. PubMed ID: 17532057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin alpha1. SciClone Pharmaceuticals.
    Billich A
    Curr Opin Investig Drugs; 2002 May; 3(5):698-707. PubMed ID: 12090542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory and enhanced antitumor activity of a modified thymosin α1 in melanoma and lung cancer.
    Wang F; Li B; Fu P; Li Q; Zheng H; Lao X
    Int J Pharm; 2018 Aug; 547(1-2):611-620. PubMed ID: 29933059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of thymosin α1 as immunomodulatory treatment for sepsis: a systematic review of randomized controlled trials.
    Liu F; Wang HM; Wang T; Zhang YM; Zhu X
    BMC Infect Dis; 2016 Sep; 16():488. PubMed ID: 27633969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients.
    Wang Z; Chen J; Zhu C; Liu L; Qi T; Shen Y; Zhang Y; Xu L; Li T; Qian Z; Steinhart CR; Lu H
    Front Immunol; 2021; 12():568789. PubMed ID: 34149679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B.
    Loggi E; Gramenzi A; Margotti M; Cursaro C; Galli S; Vitale G; Grandini E; Scuteri A; Vukotic R; Andreone P; Bernardi M
    J Viral Hepat; 2008 Jun; 15(6):442-8. PubMed ID: 18221304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivity and pharmacokinetics of two human serum albumin-thymosin alpha1-fusion proteins, rHSA-Talpha1 and rHSA-L-Talpha1, expressed in recombinant Pichia pastoris.
    Chen JH; Zhang XG; Jiang YT; Yan LY; Tang L; Yin YW; Cheng DS; Chen J; Wang M
    Cancer Immunol Immunother; 2010 Sep; 59(9):1335-45. PubMed ID: 20473755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A natural cytokine mixture (IRX-2) and interference with immune suppression induce immune mobilization and regression of head and neck cancer.
    Verastegui E; Barrera JL; Zinser J; Del Rio R; Meneses A; De La Garza J; Hadden JW
    Int J Immunopharmacol; 1997; 19(11-12):619-27. PubMed ID: 9669202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with severe sepsis using ulinastatin and thymosin alpha1: a prospective, randomized, controlled pilot study.
    Chen H; He MY; Li YM
    Chin Med J (Engl); 2009 Apr; 122(8):883-8. PubMed ID: 19493408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymosin α1 and cancer: action on immune effector and tumor target cells.
    Garaci E; Pica F; Serafino A; Balestrieri E; Matteucci C; Moroni G; Sorrentino R; Zonfrillo M; Pierimarchi P; Sinibaldi-Vallebona P
    Ann N Y Acad Sci; 2012 Oct; 1269():26-33. PubMed ID: 23045967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.